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awareness. Two subjects were discontinued by the investigators because one developed a corneal 
infiltrate and the other required a lens that was outside the fitting parameters of the protocol. 
Conclusion This study suggests that the test lens works most favorably for spherical refractive errors 
below -3.00 diopters and negligible astigmatism. This lens is safe and effective for corneal refractive 
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Purpose 
By 
MATTHEW LAMP A 
HELEN KENDRA LEE 
MAHNIA KOMALPREET MADAN 
This evaluation was conducted as part of a FDA study for the approval of 
Menicon Z™ (tisilfocon A) rigid gas permeable contact lenses for overnight 
corneal refractive therapy with the purpose of evaluating its safety and 
efficacy. 
Methods 
Eleven subjects were enrolled in the study at Pacific University College of 
Optometry. The subjects presented wearing soft contact lenses or spectacles 
who wanted to try an alternative to their current modality. The participants 
slept in the lenses approximately 8 hours each night, over the course of 6 
months, during which time their refractive errors were evaluated at fixed 
intervals. Each was fitted with a Menicon Z™ (tisilfocon A), reverse geometry 
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lens exhibiting a DK permeablility rating of 163. Upon a successful fit, 
subjects were evaluated at 24 hours, 2 weeks as well as 1, 2, and 3 months 
following their baseline visit. At the 3 month visit, the subjects were 
instructed to discontinue lens wear and return for scheduled visits at 8, 24, 48 
and 72 hours post-removat to assess the reversal effects. They then resumed 
their wearing regiment for 3 more months before returning for a final 
assessment. Visits for any other reason were recorded as an unscheduled 
appointment. 
Results 
Five of the eleven subjects completed the study with reportedly good 
subjective vision and comfort while four subjects withdrew from the study 
due to unsatisfied acuities and/or excessive lens awareness. Two subjects 
were discontinued by the investigators because one developed a corneal 
infiltrate and the other required a lens that was outside the fitting parameters 
of the protocol. 
Conclusion 
This study suggests that the test lens works most favorably for spherical 
refractive errors below -3.00 diopters and negligible astigmatism. This lens is 
safe and effective for corneal refractive therapy, when fit and managed by a 
qualified practitioner. 
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OBJECTIVE 
The objective of this FDA approval study is to assess the safety and 
efficacy of Menicon Z™ rigid gas permeable (RGP) contact lenses for overnight 
Corneal Refractive Therapy (CRT). The protocol includes a component that 
explores the reversal effects of lens removal on the cornea after three months of 
compliant therapy. 
Background Information 
Advancements in ocular science and technology have led to a greater 
understanding of corneal anatomy and physiology, which are making way for 
more innovative developments in contact lens design and materials. 
This can be seen in the creation of the Menicon Z™ lens which provides 
more oxygen permeability than any other contact lens material available for 
commercial use that still provides structural stability and good wet ability (4). 
The minimum oxygen transmissibility criterion to avoid overnight corneal 
edema to the level experienced without a contact lens in place was first 
determined by Holden and Mertz in 1984 to be a Dk/t value of 87 (1). In 1999 
Harvitt and Bonanno took into account the pH and oxygen consumption rate 
(Qo2) of the cornea and determined the new minimum CL Dk/t for oxygen 
delivery to the basal epithelial cells to be 89 in the open eye condition (2). In the 
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closed eye environment the required Dk/t to avoid anoxia in the corneal stroma 
is 125 (2). Menicon Z is unique in that it is the only material in existence that has 
an oxygen permeability (OK) value of 163 and provides enough oxygen 
permeability to allow a continuous wearing schedule without compromising 
ocular health and sacrificing mechanical strength, which has been a limiting 
factor with such materials in the past. Due to such unique properties, this 
material has been FDA approved for a continuous 30 day wearing schedule (3). 
As contact lens designs have advanced through the use of computer lathe 
manufacturing and as corneal surface changes are better monitored through the 
use of computerized topography, accelerated orthokeratology or corneal 
refractive therapy (CRT) have seen great advances since its origin and provides a 
more predictable result (7). Corneal refractive therapy reshapes the cornea by 
applying a RGP lens on the eye while asleep for 6-10 hours. Once the lens is 
removed, the cornea generally maintains this shape for several hours to days 
later. The lens consists of a reverse curve design intended to reallocate the tear 
layer and induce a pulling force to redistribute the corneal epithelium, which 
should result in a reduction of corneal sagital height and an ultimate correction 
in refractive error (16). 
Paragon has incorporated these two technologies into a single lens design 
currently undergoing FDA clinical trials. This lens design surpasses previous 
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technologies in that it not only allows oxygen permeability but also incorporates 
the benefits of not wearing contact lenses during the day and is an excellent 
alternative to refractive surgery for those who are looking for a reversible, non-
permanent option. This modality is especially convenient for patients who are 
prone to ocular dryness, athletes and people who do not want to wear correction 
during the day (6). This study is one of the participants in the approval process 
of FDA clinical trials. 
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EXPERIMENTAL DESIGN 
METHODS: 
The study is designed as a prospective multi-centered, concurrent cohort, 
controlled FDA clinical trial lasting six months using a total of 11 subjects 
enrolled at Pacific University, College of Optometry. All subjects underwent a 
standardized optometric examination at enrollment. Subjects were seen for a 
baseline fitting where a test lens was ordered, and returned for a subsequent 
dispense and 24 hour follow-up visit after one night of wear. Subjects were 
required to wear the test lenses in both eyes for up to 9 hours each night while 
asleep. As per study protocol, each subject was evaluated using subjective 
refraction, topography, logMAR acuities, keratometry, lOPs, biomicroscopy 
examination and sodium fluorescein staining. 
The patients were then seen at 2 weeks, 1 month, 2 month and 3 month 
visits after their initial dispense. At the end of three months, the subjects were 
instructed to discontinue lens wear for the next 72 hours and were seen at 8, 24, 
48 and 72 hours post-removal to assess reversal effects. Once this data was 
collected, the subjects resumed their wearing regiment for 3 more months at 
which time they returned for a final assessment. Visits for any other reason were 
recorded as unscheduled visits. 
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All test lenses used in the study were manually inspected for defects, 
damages and parameters. Lens cleaning and disinfection by the participants was 
to take place every morning upon lens removal with Unique pH contact lens care 
solution. The lenses were only replaced if damaged, lost or for cause. The 
patients were instructed to use Supraclens enzyme cleaner as needed to remove 
protein deposits that may form on the lenses. 
Inclusion Criteria: 
• Minimum of 12 years of age 
• Refractive error between -0.500 to -4.000 with or without astigmatism 
less than 1.750 with acuity correctable to 20/20 in each eye 
• Good general health 
• Willing and able to follow all instruction and keep appointments 
Exclusion criteria: 
• Presence of ocular or systemic allergies or disease 
• Use of medications that limit contact lens wear 
• Must not have worn RGP contact lenses for a minimum of 1 month 
prior to the study 
• History of corneal trauma or ocular surgery, infections, keratoconus, 
irregular cornea, recent trauma to the eyes 
• Pregnant or lactating 
• Diabetes, heart disease, immunological disease 
• Participation in another clinical study within the past 30 days 
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MATERIALS: 
• Paragon MeniconZ™ CRT lens 
• Paragon CRT diagnostic dispensing lens set 
• Humphrey Atlas Topographer 
• Biomicroscope 
• Manual Keratometer 
• Bailey-Lovie LogMAR acuity chart 
• Phoropter 
• Humphrey Non-Contact Tonometer 
• Sodium Fluorescein 
• Projected Snellen Chart 
• Peak Scope 
• Nikon digital SLR camera for photographs 
The CRT lens design consists of several parameters that can be adjusted 
for ideal fitting and treatment effects. The dispensing kit is composed of 100 
lenses, with each lens having a lens diameter of lO.Smm. 
The central treatment zone is 6.0mm across, with the back surface of this 
portion acting as the base curve. The base curve is flattened to increase myopia 
correction and steepened for hyperopia correction. 
There are three additional parameters of the Paragon CRT system that can 
be modified to produce an optimal amount of centration and applanation as 
shown in Figure 1. 
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Figure 1: Corneal Refractive Therapy Reverse Geometry Design 
1 6.0mm 
BASE CURVE 
--
Sagittal Depth 
The Return Zone Depth (RZD) is the primary factor that can be increased 
or decreased to adjust the sagittal depth with the maximal effect. For each 0.025 
increment of change in the RZD, there is a corresponding 12 microns of sagittal 
depth adjustment. 
The Landing Zone Angle (LZA) can be modified to ensure tangential 
landing on mid-peripheral cornea, as well as finer adjustments to the sagittal 
depth. For every 1 degree increment of change in the LZA, there is a 
corresponding 7 microns of sagittal depth adjustment. 
The last modifiable parameter is the overall lens diameter, which may not 
require any adjustments since the other three parameters allow sufficient control. 
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An ideal CRT fit includes a sodium fluorescein pattern that resembles a 
bulls eye with a central dark area of approximately 4mm or larger of touch, a 
zone of clearance or pooling cecocentrally, that corresponds to the return zone, as 
well as mid-peripheral touch with some peripheral edge lift controlled by the 
LZA. The lens should be centered on the pupil, with horizontal coordinates (X) 
of 0 and Vertical coordinates (Y) of 0. In the horizontal meridian,"+" represents 
millimeters of decentration nasally, while"-" indicates millimeters of 
decentration temporal. In the vertical meridian, "+" represents millimeters of 
misalignment in the superior direction, and "-"indicates millimeters of 
decentration inferiorly. Once proper alignment has been achieved, the lenses 
should be dispensed for overnight wear in order for corneal reshaping to occur 
over the prescribed time (16). 
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SAFETY AND EFFECTIVENESS ENDPOINTS: 
The study protocol was approved by the Pacific University College of 
Optometry Institutional Review Board (IRB). As a requirement, each subject 
read and signed an informed consent outlining the nature of the study, the 
potential consequences and other applicable stipulations. 
Patients were removed from the study if significant adverse events were 
identified or if subjects reported symptoms of discomfort or unacceptable acuity. 
Significant adverse events which justified removal from the study included 
significant visual acuity changes, positive slit lamp findings for corneal 
neovascularization, corneal infiltrates, corneal staining, edema, positive 
palpebral conjunctival findings and/or other adverse responses that may have 
compromised their visual system. We reserved the right to discontinue any 
participant who was unable to keep appointments or demonstrate compliance. 
Subjects were free to withdraw from the study for any reason, without 
consequence or prejudice. 
A completed subject is defined as one having completed the entire 6 
month extended wear period in accordance with the study protocol. 
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DEMOGRAPHIC DATA: 
The source population primarily included students attending the 
university and friends or spouses of current optometric students due to the 
limited availability of participants. 
The mean age of study participants was 25 years with a range of 21 to 33 
years. Gender distribution was an approximate 4 to 1 ratio of females to males as 
outlined in Figure 2. 
Figure 2: Gender Distribution 
Females.$ . 
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RESULTS 
Baseline demographic, refractive and keratometric data for all eleven patients 
have been outlined in Table 1. 
T bl 1 S a e ummaryo £B r v · ·t £nth ase me lSI 0 a f t epa Ien s 
Subject Eye Gender Age Keratometry LogMar Persciption CL 
No. ID years BVA Sphere Cylinder Hx 
1 MP OD M 25 43.00/43.25@090 51@20ft -2.00 -0.50 X 140 Soft CL 
OS 43.00/43.25@090 52@20ft -2.00 DS 
2 PR OD M 25 43.87 /45.75@100 50@20ft -3.25 -0.25 X 110 Soft CL 
OS 43.37/44.00@106 50@20ft -3.00 -0.50 x180 
3 LF OD F 28 42.00/42.75@090 49@20ft -2.25 DS Soft CL 
OS 42.00/42.50@090 50@20ft -2.25 DS 
4 NS OD F 21 42.87/43.50 @060 50@20ft -2.00 DS Soft CL 
OS 44.12/44.62@158 50@20ft -1.50 DS 
5 JP OD F 31 45.87/46.12@090 46@20ft -3.75 -0.75 X 110 Soft CL 
OS 46.37/46.50 @090 45@20ft -4.25 -0.50 X 086 
6 CN OD F 27 44.00/45.00@90 48@20ft -1.25 DS Soft CL 
OS 44.00/45.00@90 @4820ft -1.00 DS 
7 BJ OD M 24 42.12/42.87@162 50@20ft -4.50 -0.75 X 150 Soft CL 
OS 42.25/42.50@180 50@20ft -4.25 -0.50 X 015 
8 AD OD F 24 42.00/43.00@90 48@20ft -4.75 -0.25 X 130 Soft CL 
OS 42.00/43.50@80 @4820ft -3.50 -1.25 X 163 
9 TJ OD F 24 45.50/45.50@90 46@20ft -3.25 DS Soft CL 
OS 45.25/46.00@90 45@20ft -4.00 -0.50 X 164 
10 MB OD F 27 42.12/42.62 @090 50@20ft -0.50 -0.50 X 165 Soft CL 
OS 41.87/42.50 @070 51@20ft -0.50 -0.75 X 010 
11 TB OD F 27 42.75/43.50 @082 50@20ft -2.00 DS Soft CL 
OS 43.12/43.75 @085 46@20ft -2.00 DS 
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The spherical refractive errors of subjects in this study ranged from -1.00 
to -4.50 diopters with a mean power of -2.50 diopters. Astigmatism correction 
ranged from 0.00 to -1.50 diopters, with the most subjects exhibited "with the 
rule" astigmatism as shown in Figure 3. 
Figure 3: Distribution of Astigmatism 
WTR 
WTR : With the Rule Astigmatism ATR: Against the Rule Astigmatism 
The steepest cornea was 46.37 and flattest was 42.00. Mean value was 
43.12. 
The best visual acuity with habitual correction ranged from a logMar of 
45®20ft to 52@20ft with an average acuity of 49©20ft. All eleven patients were 
previously successful soft contact lenses wearers. 
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CASE REPORTS: 
Subject 1: MP 
MP is a 25 year old white male who is an elementary school teacher. His 
initial baseline visit revealed a healthy anterior segment and a refraction of: 
OD: -2.00 -0.50 X 140 
OS: -2.00 DS 
51®20ft 
52@20ft 
Based on this data and keratometric findings, the following lens was dispensed: 
OD: 8.4 .525 -33 
OS: 8.4 .525 -33 
These lenses centered well and exhibited the following findings: 
• Both Eyes X: 0, Y: 0 
• Treatment zone: 5.0 mm 
• Movement: 1.0 mm 
• Best visual acuity: Right 51®20ft 
Left 49®20ft 
In a 24 hour follow-up visit, the patient reported lens awareness and 
discomfort. LogMar acuity was 53®20ft and 54®20ft in the right and left eye 
respectively, with an over refraction of plano and +0.25D. Biomicroscopy 
revealed mild corneal staining and mild conjunctival staining and topography 
revealed well centered treatment zones in both eyes. Due to the acceptable fit, 
this was the final and only lens used on MP. 
At his two week visit, MP complained of halos and variability of vision, at 
which time an over refraction revealed a quarter of a diopter overcorrection but a 
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well centered treatment zone. At his one-month follow-up visit, the halos 
became minimal and no longer a concern. We attributed these symptoms to the 
initial adjustment period of the lens. 
After three months of wear as per the study protocol, the patient 
discontinued lens wear for 72 hours. The patient was seen at 8 hour, 24 hour, 48 
hour and 72 hour post discontinuation of lens. Patient's refractive error slowly 
returned to baseline as shown in Table 2. At 72 hours post removal, MP 
presented with the following refractive error and acuities: 
OD: -1.00 -0.25 X 001 
OS: -0.50 -0.75 X 001 
35®20ft 
46®20ft 
Even though MP' s refractive error did not completely return to baseline 
after 72 hours of lens removal, we would have expected it to return to baseline 
had he been given more time to reverse. 
Table 2: Baseline Results vs. 72 Hour Post Removal Results for MP 
Subject Eye Baseline Baseline RX 72 hour post 72 hour post-removal Rx 
LogMarVA 
Sphere Cylinder LogMarBVA Sphere Cylinder 
MP 00 51@20ft -2.00 -0.50 X 140 51@20ft -1.00 -0.25 X 001 
OS 52@20ft -2.00 OS 53®20ft -0.50 -0.75 x001 
The remainder of his visits produced an acceptable over refraction, 
negative slit lamp findings and acceptable central keratometric findings. The 
best and final visual acuity reported by MP was 54®20ft in both eyes, which is 
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slightly better than his baseline acuities. MP returned for the remaining 
scheduled visits up to 6 months where he expressed his satisfaction with his 
overall vision and comfort. This subject successfully completed the study and 
has decided to continue with this modality. 
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Subject 2: PR 
PR is a 25 year old white male who is currently a second year optometric 
student. His baseline visit revealed a healthy anterior segment and refraction of: 
OD: -3.25D - 0.25 X 110 50@20ft 
OS: - 3:00D - 0.50 X 180 50@20ft 
Based on the CRT fitting guide, he was fit with the following test lenses: 
OD: 8.4 .550 -34 
OS: 8.4 .550 -34 
These lenses centered well and exhibited the following findings: 
• Right Eye X: +0.50, Y: 0 
• Treatment zone: 4.0 mm 
• Movement: 0.75 mm 
• Best visual acuity: Right 45®20ft 
Left 50®20ft 
Left Eye X: -0.50, Y: 0 
At the 24 hour follow-up visit, the lens off over-refraction was -l.OOD and 
-0.25 -0.25 x 180 in his right and left eyes respectively, producing acuities of 
44®20ft and 50®20ft. The slit lamp examination yielded grade 2 bulbar injection 
and the patient reported obvious lens awareness accordingly . 
Based on these findings, we expected his acuities to improve at the next 
scheduled visit. At the two week visit his right and left eye unaided LogMar 
acuities were 40®20ft and 50®20ft respectively, at which point, PR expressed 
some concern about his consistently poorer acuity in his right eye, especially 
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noticed during the evenings. As a result, the landing zone angle in the right lens 
was increased to improve alignment. 
At the one month visit the patient reported the same concern, with the 
addition of halos and increased fading vision towards the end of the day. The 
lens off subjective refraction was plano in both eyes with acuities of 45®20ft and 
48®20ft in the right and left eye respectively. 
After two months from the time of the dispensing visit the patient 
presented to the clinic not having worn lenses for the past month and wished to 
discontinue from the study. The patient reported unacceptable unaided visual 
acuity. Slit lamp exam was unremarkable and the patient reported no subjective 
symptoms at the time of the visit. The subjective refraction was: 
OD-2.00 sph 
OS -1.75 -0.25 X 010 
53®20ft 
52@20ft 
As per the study protocol, PR returned for a one month post 
discontinuation visit which revealed grade 1 bulbar injection and a slow 
refractive reversal to base line as shown in Table 3. 
Table 3: Baseline Results vs. 72 Hour Post Removal Results for PR 
Subject Eye Baseline Baseline RX 72 hour post 72 hour post-removal Rx 
LogMarVA 
Sphere Cylinder LogMarBVA Sphere Cylinder 
PR OD 50@20ft -3.25 -0.25 X 110 51®20ft - 3.25 DS 
OS 50@20ft -3.00 -0.50 X 180 53®20ft -2.25 -1.00 X 002 
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Subject 3: LF 
LF is a 28 year old Asian, self-employed female who was a highly 
motivated participant in the study because she "wanted freedom from her daily 
wear soft contact lenses." LF plays softball on a regular basis, and reported 
symptoms of dry and itchiness with her current modality. Her ocular and 
systemic health was unremarkable and she reported negative ocular allergies. 
Her initial baseline visit revealed a healthy anterior segment and a refraction of: 
OD: -2.25 DS 
OS: -2.25 DS 
49®20ft 
50®20ft 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
OD: 8.6 .475 -32 
OS: 8.6 .500 -31 
These lenses centered well and exhibited the following findings: 
• Both Eyes X: -0.50, Y: -0.50 
• Treatment zone: 4.0 mm 
• Movement: 1.50 mm 
• Best visual acuity: Both Eyes 50®20ft 
The patient reported initial lens discomfort while awake, but no lens 
awareness while asleep and adjusted to them quickly. Upon the 1 day follow up 
visit, LF reported that her acuity after removing the lenses was not as good as 
with her soft lenses. Her acuities were 41®20ft and 44®20ft in her right and left 
eye respective and over-refracted at -O.SOD in both eyes. Biomicroscopy revealed 
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grade 1 conjunctival staining and injection OU. Her topographies revealed well 
centered lenses with a sufficient treatment zone. Due to the acceptable fit, this 
was the final and only lens used on LF. 
The subject returned for her scheduled visits over the next 6 months 
where her acuities improved to 50®20ft in both eyes for the remainder of the 
study with unremarkable anterior findings. Before her 2 month visit, her right 
lens broke, and therefore restarted her soft contact lens wear in that eye during 
the interim, while a new lens was ordered. Once she re-started in the test lens, 
her acuity returned to 50®20 feet in that eye. 
At her 3 month visit, LF experienced some difficulty with transient near 
blur, especially while reading. Initially, overcorrection was the suspected cause, 
however, upon an over refraction of plano in both eyes, we considered lens 
buildup was the real culprit as even small amounts of buildup can affect acuities. 
An additional cleaner was added to her lens care system, and her problem 
resolved. 
LF' s best and final acuity achieved with these lenses was 50®20 feet in 
both eyes which was comparable to her baseline visual acuities. 
As per protocol of the study, LF discontinued lenses wear after 3 months 
for 72 hours. We saw the patient at four different visits during the 72 hours 
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during which time the subject's refractive error showed a slow return towards 
baseline as outlined in Table 4. 
Table 4: Baseline Results to 72 Hour Post Removal Results for LF 
Subject Eye Baseline Baseline RX 72hourpost 72 hour post-removal 
LogMarVA 
Sphere Cylinder LogMarBVA Sphere Cylinder 
LF OD 49®20ft -2.25 DS 40@20 ft -0.50 DS 
OS 50®20ft -2.25 DS 35@20 ft -0.75 DS 
LF made her satisfaction and enthusiasm for the test lenses apparent by 
making comments such as "I cannot imagine going back to wearing soft CL." 
She reported excellent vision in both eyes, and reported no complaints. All 
ocular findings were within normal limits. 
This subject successfully completed the study and has decided to continue 
with this modality. 
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Subject 4: BJ 
BJ is a 24 year old white male, who presented at the baseline visit wearing 
spherical OW hydrogel lenses as his habitual distance correction. With his 
habitual correction, he was subjectively symptomatic for lens awareness, 
discomfort, dry and scratchiness, redness, and lens adhesion in both eyes. 
His initial baseline visit revealed grade 1 corneal neovascularization and 
trace pigment on the corneal endothelium in both eyes. His refraction and 
acuities were: 
00:-4.50-0.75 X 150 
OS: -4.25 -0.50 X 015 
50@20ft 
50®20ft 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
00:9.10.550-32 
OS: 9.00 .550-33 
These lenses centered well and exhibited the following findings: 
• Both Eyes X: 0, Y: 0 
• Treatment zone: 5.0 mm 
• Movement: 0.75 mm 
At the first visit following overnight lens wear the SCOR was +0.25 0 in 
both eyes with acuities of 53®20ft and 54®20ft in the right and left eye 
respectively. The lens off refraction revealed: 
00: -1.25-0.25 X 090 
OS: -1.00 OS 
38®20ft 
41®20ft 
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Grade 3 and grade 2 corneal staining was noted in the right and left eye 
respectively. The patient was instructed to discontinue lens wear for the next 24 
hours before resuming with the study to allow the staining to resolve. 
BJ reported at the two week visit that he "liked being able to see without 
contact lenses during the day," however, he was "never fully corrected and that 
made driving difficult." During this visit, we decided to increase the landing 
zone angle of the left lens to improve alignment. 
Upon wearing the new lenses for the first night, BJ returned to clinic in the 
morning one hour after awakening, with lens adherence in the left eye, leaving 
an impression ring and dimple veil upon lens removal. The subjective refraction 
was plano with an acuity of 51@20ft. As the patient continued wearing with the 
test lens, the adhesion resolved and he was closely monitored for any further 
adhesions. 
Two months after enrollment, the patient damaged his right lens, at which 
time, we decided to steepen the base curve slightly in an attempt to improve the 
refractive error in that eye. At this time, the left lens had developed a substantial 
amount of protein deposit and was therefore cleaned with Lobob Extra Strength 
Cleaner. The patient contacted the clinic within a few days to report a subjective 
improvement in acuities, overall comfort and treatment since the cleaning. 
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At two and a half months, BJ was seen for an unscheduled visit as he 
developed another lens adhesion in the left eye. Although the etiology of RGP 
lens binding is unclear, this problem can be solved by steepening the base curve 
and/or flattening the peripheral curve (9) . BJ's test lens was therefore steepened 
by increasing the return zone depth from .500 to .525 to ultimately increase the 
sagittal depth. 
At 3 months, BJ discontinued lens wear in the left eye only, as dictated by 
the study at which time his left cornea demonstrated a slow return in refractive 
error toward baseline as expected at -2.75 -1.00 x 046 with an acuity of 38®20ft. 
BJ started the new test lens after the 72 hour post-removal visit, in hopes 
that the corneal tissue would have returned more towards its original shape 
before trying to remold the cornea to the parameters of the new lens. Upon 
returning to clinic after the first night of wear the lens continued to adhere. A 
new lens was ordered once again, with an even steeper base curve to reduce the 
overcorrection and increase the sagittal depth. 
The new lens was once again, sent home to be worn over night by the 
subject, and once again, lens adherence occurred upon awakening the next 
morning. The subject continued with this lens, and returned one week later for 
an evaluation, at this time, the right lens was determined to be a good fit, 
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however, the left lens was still adherent. The patient was closely monitored for 
further adherence symptoms. 
Six months after enrollment into the study the patient returned to clinic 
with concerns of discomfort and lens awareness, blurred vision, redness, and 
lens adhesion in the right eye, and lens adhesion in the left eye. Slit lamp 
examination revealed grade 1 staining OU, grade 2 injection OD, and a lmm 
peripheral infiltrate OD. This was assessed to be a moderate adverse event and 
proper paper work was completed to discontinue this subject from the study as 
outlined by the study protocol. It was decided not to culture the infiltrate 
because in the investigators opinion, the infiltrate appeared to be sterile and 
further manipulation it would only disrupt the epithelium. The prognosis was 
guarded and the subject was closely monitored. Upon returning to clinic the 
next day the peripheral infiltrate showed overlying staining, estimated to be 1 x 
l.Smm. The patient was given Vigamox ophthalmic solution to instill in the right 
eye four times a day, prophylactically. Within two days, the peripheral infiltrate 
was noted to be minimal but the patient was instructed to continue the Vigamox 
another 24 hours before discontinuing. Upon a one week follow up, the adverse 
reaction had had completely resolved. 
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The reason for discontinuation was cited as a poor outcome with 
treatment or re-treatment lenses in addition to recurrent lens adherence in the 
left eye and poor visual outcome in the right eye. 
There were a series of two post-discontinuation visits, each separated by 
one month, to ensure the patient had returned to baseline and all other ocular 
findings were within normal limits as shown by Table 5. These visits proved to 
show that the subject had returned to baseline and all other ocular findings were 
acceptable. 
Table 5: Baseline Results vs. Discontinuation Results for BJ 
Subject Eye Baseline Baseline Post Post Discontinuation 
LogMarVA RX Discontinuation Rx 
Sphere Cylinder LogMarBVA Sphere Cylinder 
BJ OD 50®20ft -4.50 -0.75 53@20 ft -4.25 -0.75 
OS 50®20ft -4.25 -0.25 52®20 ft -4.00 -0.50 
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Subject 5: CN 
CN is a 26 year old white female librarian, who reports wearing her 
current soft contact lenses for 15-18 hours making her symptomatic for ~~very 
tired and dry eyes." 
Her ocular and systemic health was unremarkable with the exception of 
mild seasonal allergies. 
Her initial baseline visit revealed a healthy anterior segment and a refraction of: 
OD: -1.25 DS 
OS: -1.00 OS 
48@20ft 
48®20ft 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
00: 8.00 .525 -34 
OS: 7.90 .525-34 
These lenses centered well and exhibited the following findings: 
• Both Eyes X: 0, Y: -0.50 
• Treatment zone: 4.0 mm 
• Movement: 0.75 mm 
• Best visual acuity: right eye 51®20ft, left eye 47®20ft 
The initial spherical over-refraction revealed +0.25D and plano in the right 
and left eye respectively. The subject reported some initial awareness with the 
test lenses but quickly adjusted to them after dispensing. 
Upon her 24 hour follow-up visit, CN reported good lens comfort and 
vision. Her acuities were 45®20ft and 46®20ft in the right and left eye 
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respectively, at which time she over-refracted at +0.25 and plano. Topography 
revealed that the lenses centered well at night and a good size treatment zone 
was also apparent with unremarkable boiomicroscopy findings. Due to the 
acceptable fit, this was the final and only lens used on CN. 
We saw CN on a continuous basis for the next 6 months. She reported 
having trouble getting the contact lenses in and out but otherwise was very 
happy with her vision throughout the day. The best visual acuity that CN 
achieved from this modality was 51@20ft and 53@20ft in the right and left eye 
respectively, indicating an improvement over her baseline acuities. CN's acuities 
remained fairly stable at approximately 50@20ft for the duration of the study 
with consistently unremarkable slit lamp findings. 
At the 3 month mark, CN to discontinue lens wear for 72 hours, at which 
time, her refractive error slowly returned toward baseline as demonstrated in 
Table 6. 
Table 6: Baseline results vs. 72 hour post removal results for CN 
Subject Eye Baseline BaselineRX 72 hour post-removal 72 hour post removal Rx 
LogMarVA 
Sphere Cylinder LogMarBVA Sphere Cylinder 
CN OD 48®20ft -1.25 OS 34®20 ft -0.50 OS 
OS 48@20ft -1.00 OS 34®20 ft -0.50 OS 
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CN completed the remainder of her visits and continued with good 
vision, unremarkable anterior segment findings and excellent comfort. 
This subject successfully completed the study and has decided to continue 
with this modality. 
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Subject 6: AD 
AD is a 24 year old white female optometry student who has been 
wearing soft contact lenses for since childhood. She reports good vision with her 
current soft contact lens prescription and her only concern is occasional dry and 
itchy eyes, especially at the end of the day. Her ocular and systemic health is 
unremarkable and she is currently not taking any medications. 
Her initial baseline visit revealed a healthy anterior segment and a refraction of: 
OD: -4.75 - 0.25 X 130 
OS: -3.50 - 1.25 X 163 
48®20ft 
48®20ft 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
00: 9.10 .525 -34 
OS: 8.90 .525 -34 
These lenses centered well and exhibited the following findings: 
• Both Eyes X: +0.50, Y: + 1.00 
• Treatment zone: 4.0 mm 
• Movement: 1.00 mm 
• Best visual acuity: Both Eyes 50®20ft 
The patient reported acute lens awareness and distress initially but slowly 
improved as the study progressed. The dispensed lenses produced a spherical 
over-refraction of +0.250 and +0.500 in her right and left eye respectively. 
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At her 24 hour follow-up visit, her acuities were 11®20ft and 36@20ft in 
the right and left eye respectively with an over refraction of -1.50 and -0.50. 
Biomicropscopy was unremarkable. 
Considering AD was a moderate myope, we expected a longer duration 
for corneal reshaping to occur. Topography confirmed these expectations with a 
well centered, yet under corrected treatment zone. Based on this data, we 
expected AD's vision to improve within the next few days as corneal molding 
pursued. 
AD returned for her 2 week visit, at which time acuities were recoreded as 
38@20ft and 25@20ft in the right and left eye respectively with an over refraction 
of -1.50DS and+ 1.50-1.00 x 174. Slit lamp findings were unremarkable; however 
the patient still reported some lens awareness and discomfort. 
New test lenses that increased return zone depth and reduced edge lift 
were ordered with the following parameters. 
OD: 9.00 .550 -34 
OS: 8.90 .550-34 
Before theses lenses could be dispensed, the subject submitted a request to 
withdraw from the study, indicating poor lens tolerance, poor acuities and 
fluctuating vision as the main reasons for her discontinuation. AD was relying 
on her glasses to see, however due to her partially reshaped corneas, they were 
too strong and often elicited headaches. As dictated by the study guidelines, AD 
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returned for a discontinuation visit and a 1 month post-discontinuation visit to 
ensure that her vision had returned to baseline. Please refer to Table 7. 
Table 7: Baseline Results vs. Discontinuation Results for AD 
Subject Eye Baseline Baseline RX 1 month post 1 month post 
LogMarVA discontinuation discontinuation 
LogMarBVA Rx 
Sphere Cylinder Sphere Cylinder 
AD 00 48®20ft -4.25 -0.25x130 49®20 ft -4.25 OS 
OS 48®20ft -3.25 -1.25x163 46®20 ft -3.25 -1.00x175 
32 
Subject 7: TJ 
TJ is a 25 year old white female who is currently an optometry student 
and relies predominantly on glasses to correct her vision, however will use soft 
lenses when necessary. Her main complain is that she cannot wear glasses to 
play soccer, and "they often get wet and fog up in the cold, rainy weather." 
Her ocular and systemic health was unremarkable and indicated no ocular 
allergies. Her initial baseline visit revealed a healthy anterior segment and a 
refraction of: 
00: -3.25 OS 
OS: -4.00 - 0.50 X 164 
46®20ft 
45®20ft 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
00: 8.20 .525 -34 
OS: 8.40 .550 -34 
These lenses centered well and exhibited the following findings: 
• Both Eyes X: 0, Y: +0.50 
• Treatment zone: 4.0 mm 
• Movement: 1.25 mm 
• Best visual acuity: Right eye 50®20ft, left eye 49®20ft 
The patient reported acute lens awareness and discomfort immediately 
upon lens insertion at the dispensing visit. The dispensed lenses produced a 
spherical over-refraction of plano in both eyes. 
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TJ did not return for her scheduled visits indicating that she was having 
trouble falling asleep with the lenses on her eyes, due to apparent lens 
awareness. After repeated attempts, TJ returned to the clinic after having 
successfully worn her lenses for 6 hours the night before. At the morning follow 
up visit, TJ presented with acuities of 22®20ft and 10®20ft in the right and left 
eye respectively, with an over refraction of -2.50D and -4.00D. Considering TJ 
was a moderate myope, we expected a longer duration for substantial corneal 
reshaping to occur. However, due to the highly uncomfortable properties of the 
lens, TJ withdrew from the study at this visit. 
As indicated by the study guidelines, TJ returned for a 1 month post 
discontinuation visit to ensure that her vision had returned to normal within this 
time. Table 8 shows a comparison of her baseline refractive error to her 1 month 
post discontinuation visit. All biomicropscopy findings were within normal 
limits. 
Table 8: Baseline Results vs. Discontinuation Results for TJ 
Subject Eye Baseline Baseline RX 1 month post 1 month post 
LogMarVA discontinuation discontinuation Rx 
Sphere Cylinder LogMarBVA Sphere Cylinder 
TJ 00 46®20ft -3.25 -0.25x130 45®20 ft -3.00 OS 
OS 45®20ft -4.00 -0.50x 164 48®20 ft -4.00 OS 
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Subject 8: NS 
NS is a 21 year old white female, who is currently training within the 
armed forces to become a military negotiator. NS reported wearing her spherical 
hydrogel soft contact lenses for about 20 hours a day, seven days per week. 
Her systemic health was unremarkable upon initial evaluation and she 
reported no allergies or conditions that would exclude her from the study. The 
subjects reported being a smoker and an occasional alcohol user. 
Her initial baseline visit revealed grade 1 corneal neovascuarlization and 
grade 1 conjunctival injection in both eyes with a refraction of: 
OD: -2.00 DS 
OS: -1.50 OS 
50@20ft 
50@ 20ft 
19@5ft (unaided) 
25®5ft (unaided) 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
OD: 8.40 .525 -33 
OS: 8.00 .525 -33 
These lenses centered slightly low and exhibited the following findings: 
• Both Eyes X: 0, Y: -0.50 
• Treatment zone: 4.0 mm 
• Movement: 1.00 mm 
• Best visual acuity: Right eye 44®20ft and left eye 38®20ft 
These lenses were dispensed and produced a spherical over-refraction of 
+ 1.250 and plano OD and OS respectively. The subject reported initial 
discomfort of the lenses but slowly adjusted to them. 
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Upon her 24 hour follow-up visit, NS reported continued lens discomfort 
in both eyes upon awakening and presented with acuities of 50@20ft and 50®20ft 
in the right and left eye respectively with an over refraction of plano and -0.500. 
Slit lamp findings revealed slight conjunctival injection with no other 
abnormal findings from her initial visit. Her topographical maps revealed that 
the lenses centered quite well in the closed eye position and the treatment zone 
appeared to be sufficient. 
At her two week visit, NS reported great vision in the distance, but 
decreased vision at near, having to bring reading material closer and having a 
harder time focusing on the computer. At this time, she presented with some 
central superficial punctuate keratitis and slight injection in both eyes but was 
encouraged to continue with the same lenses. 
By her one month visit, the near complaints dissipated, lens comfort 
improved dramatically, and she reported no other problems. By her two month 
visit, her acuities improved to 52 and 50 in the right and left eye respectively at 
20ft. 
Due to the satisfactory fit and vision, only one lens was used for NS, 
though a lost right lens was replaced for the subject on one occasion. 
Table 9 shows NS' s results from the 72 hour post removal visit and reveals 
a slow return of refractive error to baseline. 
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Table 9: Baseline Results vs. 72 Hour Post Removal Results for NS 
1 Subject Eye Baseline Baseline RX 72 hour post- removal 72 hour post-removal 
LogMarVA Sphere Cylinder LogMarBVA Sphere Cylinder 
NS OD 50@20ft -2.00 DS 35@20 ft -1.25 DS 
OS 50@20ft -1.50 DS 45@20 ft -0 .75 DS 
The patient reports overall satisfaction with the modality and appreciates 
the freedom from contact lens wear during the day. Because NS is now enrolled 
in boot camp, she is not permitted to continue with this modality, however, she 
has expressed great interest in continuing with this therapy after she completes 
her training requirements. 
This subject successfully completed the study and has decided to continue 
with this modality. 
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Subject 9: MB 
MB is a 27 year old white female who is a stay at home mom. She reports 
wearing her current hydrogel soft contact lenses for approximately 12 hours each 
day, seven days per week. 
Her ocular and systemic health was unremarkable upon initial evaluation. 
Her initial baseline visit revealed a healthy anterior segment and a refraction of: 
OD: -0.50 -0.50 X 165 
OS: -0.50 -0.75 X 010 
50@20ft 
51®20ft 
39®5ft (unaided) 
34@5ft (unaided) 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
OD: 8.20 .500-33 
OS: 8.30 .475 -32 
These lenses centered slightly high and exhibited the following findings: 
• Both Eyes X: 0, Y: + 1.00 
• Treatment zone: 4.0 mm 
• Movement: 1.00 mm 
• Best visual acuity: Right eye 45@20ft, left eye 47@20ft 
These lenses were dispensed and produced a spherical over-refraction of 
plano in both eyes. The patient reported initial awareness of the lenses but 
quickly adjusted to them. 
Upon her one day follow-up the next morning, MB reported good lens 
comfort in both eyes and presented with acuities of 47@20ft and 50@20ft in the 
right and left eye respectively with an over refraction of +0.25D in both eyes. 
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MB however did report symptoms of itching and burning on occasion, 
which was supported by slit lamp findings of grade 1 injection, mild central 
staining and grade 1 tarsal abnormalities. Her topographical maps revealed that 
the lenses centered well in the closed eye position and the treatment zone 
appeared to be sufficient. 
At her one month visit, MB reported unequal lens awareness between the 
two eyes, with the left eye being more bothersome than the right. She 
experienced quick instances of sharp pain once in a while throughout the night 
in her left eye. Upon her slit lamp evaluation, we discovered some corneal 
staining and tarsal abnormalities, in her left eye. 
After careful examination of MB' s left lens, we discovered that there were 
obvious lathe marks on the lens, indicating poor manufacturing. We re-ordered 
a left lens and refit MB, which resolved the problem upon lens insertion. 
At her 3 month visit, MB withdrew from the study, indicating lens 
discomfort issues as the reason for discontinuation, even though she reported her 
appreciation for the crispness of vision. We saw MB for a one month post 
discontinuation visit to ensure her refractive error returned to baseline. 
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Subject 10: JP 
JP is a 31 year old white female who is currently a naturopathic graduate 
student in Portland, Oregon. She reported wearing her current spherical 
hydrogel soft lenses for about 16 hours a day, seven days a week. Her ocular and 
systemic health was unremarkable and with no other conditions that excluded 
her from the study. Her initial baseline visit revealed a healthy anterior segment 
and a refraction of: 
OD: -3.75 -0.75 xllO 
OS: -4.25 -0.50 x086 
46@20ft 
45@20ft 
5®10ft (unaided) 
5®10ft (Unaided) 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
OD: 8.20 .575 -34 
OS: 8.30 .575 -34 
When placed on her eyes, these lenses were well centered but produced a 
treatment zone of 2mm in both eyes. As a result, we ordered a steeper fit of: 
OD: 8.30 .525 -36 
OS: 8.30 .525 -36 
These lenses centered well in the right eye but centered poorly in the left with the 
following findings: 
• Right eye X: 0, Y: 0, Left eye X:+ 1.00, Y: + 1.00 
• Treatment zone: right eye 5.0 mm, left eye 3.00 mm 
• Movement: 0.50 mm 
• Best visual acuity: Right eye 46@20ft, left eye 44@20ft 
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These lenses produced a spherical over-refraction of plano and +0.25D in 
the right and left eye respectively. Due to the poor fit in her left eye, we decided 
not to dispense these but rather reorder a new left lens before dispensing. 
The following lenses were dispensed: 
OD: 8.30 .525 -36 
OS: 8.30 .550 -37 
Upon her one day follow-up evaluation, she exhibited marked inferior 
staining, potentially from either a suspected lagophthalmos or chronic 
blepharitis toxicity. As a result, we discontinued contact lens wear for one week 
and made adjustments to improve the fit. After two more attempts, the 
following lens was extrapolated as the best fit for JP' s very steep corneas. 
OD: 8.30 .525 -38 
OS: 8.30 .525 -38 
When this lens was ordered however, we discovered that the landing zone 
required for JP could not be made because the parameter was outside of the 
study protocol. As a result we had to discontinue the subject from the study. 
We never managed to get any lenses on her for more than a one day follow-up 
because of the challenging fit. JP returned for her post-discontinuation visits to 
ensure her refractive error returned to baseline. 
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Subject 11: TB 
TB is a 27 year old white female who is a spouse of an optometry student 
and is currently working as a bank manager. She reported wearing her current 
soft lenses for approximately 17 hours a day, seven days per week. She dislikes 
wearing soft contact lenses because of the inconvenience and dry eye symptoms 
that accompany this modality. 
Her ocular and systemic health was unremarkable and she reported mild 
seasonal allergies. Her initial baseline visit revealed a healthy anterior segment 
and a refraction of: 
OD: -3.00 DS 
OS: -3.50 DS 
50@20ft 
46®20ft 
15®5ft (unaided) 
15®5ft (unaided) 
Based on the CRT fitting guide, LF was fit with the following test lenses: 
OD: 8.50 .550 -34 
OS: 8.50 .550 -34 
These lenses centered slightly high and exhibited the following findings: 
• Both Eyes X: 0, Y: + 1.00 
• Treatment zone: 5.0 mm 
• Movement: 1.50 mm 
• Best visual acuity: right eye 44®20ft, left eye 46®20ft 
These lenses were dispensed and produced a spherical over-refraction of 
+0.75D and +1.00 in the right and left eye respectively. Patient reported initial 
awareness of the lenses but quickly adjusted to them. 
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On her one day follow-up visit, TB reported good lens comfort and lens 
off acuities of 17®20ft and 11®20ft with and an over refraction of 0.50 -1.25 x 012 
OD and -0.25 -1.00 x 084 in the right and left eye respectively. Slit lamp findings 
revealed grade one central staining in both eyes and grade 1 conjunctival 
injection in both eyes. Her topographical maps revealed that the lenses centered 
well in the closed eye position. Treatment zone size appeared to be sufficient. 
TB returned for her scheduled visits for the next 6 months at which time, 
four revisions were made to the lenses for each eye, either because of poor end 
acuity or a poor fit. Table 10 lists a summary of all the trialed lenses for TB: 
Table 10: Summary of lenses fit on subject TB 
! 8.50 .550 -34 ! 8.50 .550 -34 
~: -··-·----·-- ---~-----·----·-·--·-----< 
! 8.50 .525 -35 8.50 .575 -33 
f--------- ·--~ 
. 8.50 .525 -34 8.40 .550 -35 
' 
Final CL ~---iso ~52S -35 8.40 .550 -34 
The final contact lenses we dispensed produced final unaided acuities of 
45®20ft for both eyes and an over refraction of +0.75D and -0.25D in the right and 
left eye respectively. 
Although TB was happy with the end outcome, and end acuities, fitting 
this subject was a challenge. For instance, during her second week of the study, 
TB experienced an episode of seasonal allergies whereby we prescribed Patanol 
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to be instilled twice a day and discontinued her from lens wear for a week until 
her episode subsided. 
Then at the two month mark, TB experienced significant glare problems 
while driving at night. Her topographies revealed that even though in the open 
eye condition, the lenses clearly rode high, in the sleeping position; they actually 
rode low, which indicated a lens parameter change. 
Table 11 shows TB' s results from the 72 hour post removal period which 
showed a clear progression of her refractive error back toward baseline. 
Table 11: Baseline Results vs. 72 Hour Post Removal Results for TB 
Subject Eye Baseline Baseline RX 72 hour post-removal 72 hour post-removal Rx 
LogMarVA 
Sphere Cylinder 
LogMarBVA 
Sphere Cylinder 
TB 00 50@20ft -3.00 OS 9@20 ft -1.00 -0.50 x005 
OS 46@20ft -3.50 OS 9@20 ft -1 .00 -1.25 X 045 
The patient reported overall satisfaction with the modality and 
appreciates the freedom from contact lens wear during the day. Though she 
reported that her visual acuities are not always stable, she did notice substantial 
improvement in her dry eye symptoms. This subject successfully completed the 
study and has decided to continue with this modality. 
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DISCUSSION I CONCLUSION 
The Paragon-Z CRT contact lens unites two technologies into a single lens 
design that not only allows unrestricted oxygen entry to the cornea but also 
incorporates the benefits of not wearing contact lenses during the day. Of the 
eleven subjects, five subjects successfully completed the study and did very well 
with this modality. These five patients had little trouble adapting to the lenses 
and wearing schedule and often commented on the comfort and convenience 
over their previous correction during waking hours. 
Four of the eleven patients withdrew from the study, citing significant 
lens discomfort or poor end acuities as the reason. One of the eleven subjects (JP) 
was discontinued because her corneal profile was outside of the fitting 
parameters of the study lenses. And one out of the eleven subjects experienced 
persistent lens adherence over the last five months of the study. Lens parameters 
were modified in an effort to eliminate this and still maintain sufficient corneal 
aplanation in the closed eye condition; however, all changes produced little 
resolution. Figure 4 shows a summary of how many subjects and their reasons 
for withdrawing from the study. 
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Figure 4: Reasons for Subject Discontinuation 
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Rigid gas-permeable (RGP) lens adherence has been reported in both daily 
and extended wear, although it is considered to be more common with the latter 
(8,9). The mechanism for daily wear RGP lens adherence is likely similar to that 
of extended wear (9). An adhesive effect is thought to form between the cornea 
and the posterior lens surface by a thin, highly viscous retro-lens tear film (9). In 
1989, Swarbrick and Holden proposed that lens binding is primarily a patient-
dependent phenomenon rather than lens parameter-dependent (10). Swarbrick 
and Eiden found variable success in eliminating lens adherence by changing lens 
parameters (8,9). In some cases lens modifications helped eliminate or decrease 
lens adherence and in some cases no improvement was noted. We also found 
this to be the case with BJ. Some modifications in the lens parameters seemed to 
decrease the lens adherence; however it was never completely eliminated. We 
46 
think this is not due to the design or material of the lens but rather patient 
dependent. Additionally, it has been recommended to instill two to three drops 
of sterile, unpreserved saline on the eye before sleeping at night and upon 
wakening to decrease adherence (15). This is thought to initiate lens movement 
and flush debris from behind the lens (8, 15). 
BJ presented with additional complications associated with RGP lens 
adherence including corneal indentation ring, distorted central cornea, 
peripheral and central corneal staining, and infiltrative keratitis. The earliest 
stages of contact lens peripheral ulcer (CLPU) and microbial keratitis (MK) are 
often difficult to differentiate (11). The key factors to monitor are discomfort, 
discharge, lesion size, an anterior chamber reaction, and the shape of the lesion 
(12). From the patient's initial presentation until complete resolution, the signs 
and symptoms pointed toward a sterile infiltrate versus an infectious ulcer and 
the patient was managed accordingly. These complications are not thought to be 
associated with this lens design but rather a function of overnight lens wear and 
patient physiology. 
In addition to the risk of lens adherence, other adverse effects are possible 
and expected with extended RGP lens wear, some of which include corneal 
edema, corneal staining, redness, tearing, irritation, and some distortion of 
vision. These are usually a temporary occurrence and generally resolve with 
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time. As expected, some of the study subjects experienced varying degrees of 
these side effects. 
The results of this study suggest that a predictor of success with CRT may 
be an individual's baseline refractive error. This study found that for refractive 
errors greater than -3.00 diopters of spherical correction, CRT with the menicon Z 
lens, creates a greater challenge in the fitting process, as demonstrated by the 
increased number of lens changes and fitting attempts required by each subject 
with higher refractive errors and by the higher number of discontinuations for 
this refractive error group as shown in Figure 5 and Figure 6. In addition, these 
subjects presented with more reported adverse events throughout the duration 
of 6 months than the subjects with lower refractive errors. 
Figure 5: Equivalent Sphere vs. Status in Study 
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Figure 6: Number of Lens Changes in the 11Completed" 
vs. 11Discontinued" Group 
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The study also suggests that CRT with the lenses under investigation may 
be additionally successful if the subject has no astigmatic component in their 
correction as shown in Error! Reference source not found .. 
Figure 7: Astigmatism in the 11Completed" vs. 11Discontinued" Group 
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The subjects with baseline refractions below -3.00 diopters were observed 
to be the most satisfied and motivated to continue with this therapy. In fact, at 
the completion of the study, these five individuals indicated that they would 
continue using the study lenses as their primary form of refractive correction. 
Figure 8 shows the status of best visual acuity achieved by these subjects with 
CRT compared to their baseline acuities. 
Figure 8: Status of Acuities Achieved in the study 
Stahts of Final BVA compared to Initial BVA 
This study also suggests that 72 hours of lens wear discontinuation is not 
enough time for remolded corneas to return to baseline; however all the subjects 
reached 100% recovery by the 1 month mark. And of the eleven subjects, one 
subject developed a corneal ulcer. In retrospect, we recognize that had we 
removed the subject from the study earlier, a corneal ulcer could have been 
prevented. The subject presented with early signs of being a poor candidate 
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when he developed persistent lens adhesions and adverse reactions throughout 
most of the study, even with lens adjustments. 
In conclusion, although all over night contact lens wear should be 
approached with caution by practitioners and patients alike, with careful clinical 
monitoring for adverse events, and appropriate recognition of a poor candidate, 
in our opinion, the CRT Menicon Z™ lens appears to be a safe and effective 
alternative to other lens modalities and refractive surgery. 
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APPENDIX 
T bl 12 S a e urnmary o f B r v· ·t f nth ti t aseme lSI 0 a epa ens 
Subject Eye Gender Age Keratometry LogMar Persciption CL 
No. ID years BVA Sphere Cylinder Hx 
1 MP 00 M 25 43.00/43.25®090 51@20ft -2.00 -0.50 X 140 Soft CL 
OS 43.00/43.25®090 52@20ft -2.00 OS 
2 PR 00 M 25 43.87/45.75®100 50®20ft -3.25 -0.25 X 110 Soft CL 
OS 43.37/44.00@106 50@20ft -3.00 -0.50 x180 
3 LF 00 F 28 42.00/42.75®090 49@20ft -2.25 OS Soft CL 
OS 42.00/42.50@090 50@20ft -2.25 OS 
4 NS 00 F 21 42.87/43.50 @060 50@20ft -2.00 DS Soft CL 
OS 44.12/44.62®158 50@20ft -1.50 DS 
5 JP OD F 31 45.87 /46.12®090 46@20ft -3.75 -0.75 X 110 Soft CL 
OS 46.37/46.50 ®090 45@20ft -4.25 -0.50 X 086 
6 CN OD F 27 44.00/45.00®90 48@20ft -1.25 OS Soft CL 
OS 44.00/45.00®90 @4820ft -1.00 OS 
7 BJ OD M 24 42.12/42.87®162 50®20ft -4.50 -0.75 X 150 Soft CL 
OS 42.25/42.50®180 50®20ft -4.25 -0.50 X 015 
8 AD OD F 24 42.00/43.00@90 48®20ft -4.75 -0.25 X 130 Soft CL 
OS 42.00/43.50®80 @4820ft -3.50 -1.25 X 163 
9 TJ OD F 24 45.50/45.50@90 46®20ft -3.25 DS Soft CL 
OS 45.25/46.00@90 45@20ft -4.00 -0.50 X 164 
10 MB 00 F 27 42.12/42.62 @090 50®20ft -0.50 -0.50 X 165 Soft CL 
OS 41.87/42.50 ®070 51@20ft -0.50 -0.75 X 010 
11 TB OD F 27 42.75/43.50 @082 50®20ft -2.00 DS Soft CL 
OS 43.12/43.75 @085 46®20ft -2.00 OS 
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